Characterization of a cancer stem cell-like side population derived from human pancreatic adenocarcinoma cells

Tumori

Volumn 96, Issue 6, 2010, Pages 985-992

  Zhang, Shi Neng ^a   Huang, Feng Ting ^a   Huang, Yi Jun ^b   Zhong, Wa ^a   Yu, Zhong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cancer stem cell; Pancreatic adenocarcinoma; Side population cells

Indexed keywords

CD133 ANTIGEN; GEMCITABINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CARCINOMA CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CELL STRUCTURE; CLONOGENESIS; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; SIDE POPULATION CELL;

EID: 79551493018     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/548.6520     Document Type: Article

References (37)

1. American Cancer Society: Cancer Facts and Figures 2008. Atlanta, Ga: American Cancer Society, 2008. Also available online. Last accessed October 1, 2008.
2. Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. Nature, 414: 105-111, 2001.
3. Beachy PA, Karhadkar SS, Berman DM: Tissue repair and stem cell renewal in carcinogenesis. Nature, 432: 324-331, 2004.
4. Wulf GG, Wang RY, Kuehnle I, Weidner D, Marini F, Brenner MK, Andreeff M, Goodell MA: A leukemic stemcell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood, 98: 1166-1173, 2001.
5. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA, 100: 3983-3988, 2003.
6. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res, 63: 5821-5828, 2003.
7. Kondo T, Setoguchi T, Taga T: Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA, 101: 781-786, 2004.
8. Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, Farkas DL, Black KL, Yu JS: Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene, 23: 9392-9400, 2004.
9. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB: Identification of human brain tumour initiating cells. Nature, 432: 281-282, 2004.
10. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, Nakauchi H, Taniguchi H: Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology, 44: 240-251, 2006.
11. Wang J, Guo LP, Chen LZ, Zeng YX, Lu SH: Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res, 67: 3716-3721 2007.
12. Li CW, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM: Identification of Pancreatic cancer stem cells. Cancer Res, 67: 1030-1037, 2007.
13. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 1: 241-242, 2007.
14. Hadnagy A, Gaboury L, Beaulieu R, Balicki D: SP analysis may be used to identify cancer stem cell populations. Exp Cell Res, 312: 3701-3710, 2006.
15. Challen GA, Little MH: A side order of stem cells: the SP phenotype. Stem Cells, 24: 3-12, 2006.
16. Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G, Grupp SA, Sieff CA, Mulligan RC, Johnson RP: Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med, 3: 1337-1345, 1997.
17. Scharenberg CW, Harkey MA, Torok-Storb B: The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood, 99: 507-512, 2002.
18. Kim M, Turnquist H, Jackson J, Sgagias M, Yan Y, Gong M, Dean M, Sharp JG, Cowan K: The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res, 8: 22-28, 2002.
19. Bunting KD: ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells, 20: 11-20, 2002.
20. Wang FP, Wang L, Yang JS, Nomura M, Miyamoto K: Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells. Biol PharmBull, 28: 1979-1982, 2005.
21. Gréen H, Söderkvist P, Rosenberg P, Horvath G, Peterson C: mdr-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy. Clin Cancer Res, 12: 854-859, 2006.
22. Hirschmann-Jax C, Foster AE, Wulf GG , Wulf GG, Nuchtern JG, Jax TW, Gobel U, Goodell MA, Brenner MK: A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA, 101: 14228-14233, 2004.
23. Sparreboom A, Loos WJ, Burger H, Sissung TM, Verweij J, Figg WD, Nooter K, Gelderblom H: Effect of ABCG2 genotype on the oral bioavailability of topotecan. Cancer Biol Ther, 4: 650-658, 2005.
24. Chen ZS, Robey RW, Belinsky MG , Shchaveleva I, Ren XQ, Sugimoto Y, Ross DD, Bates SE, Kruh GD: Transport of methotrexate, methotrexate polyglutamates, and 17betaestradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res, 63: 4048-4054, 2003.
25. Burger H, van Tol H, Boersma AW, Brok M, Wiemer EA, Stoter G, Nooter K: Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump. Blood, 104: 2940-2942, 2004.
26. Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF, Mori M: Charaterization of a side population of cancer cells from human gastrointestinal system. Stem Cells, 24: 506-513, 2006.
27. Sung JM, Cho HJ, Yi H, Lee CH, Kim HS, Kim DK, Abd El- Aty AM, KimJ S, Landowski CP, Hediger MA, Shin HC: Characterization of a stem cell population in lung cancer A549 cells. Biochem Biophys Res Commun, 371: 163-167, 2008.
28. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG: Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res, 65: 6207-6219, 2005.
29. Shi GM, Xu Y, Fan J, Zhou J, Yang XR, Qiu SJ, Liao Y, Wu WZ, Ji Y, Ke AW, Ding ZB, He YZ, Wu B, Yang GH, Qin WZ, Zhang W, Zu J, Min ZH, Wu ZQ: Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials. J Cancer Res Clin Oncol, 134: 1155-1163, 2008.
30. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R: Identification and expansion of human colon-cancer-initiating cells. Nature, 445: 111-115, 2007.
31. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res, 65: 10946-10951, 2005.
32. Dou J, Pan M, Wen P, Li Y, Tang Q, Chu L, Zhao F, Jiang C, Hu W, Hu K, Gu N: Isolation and identification of cancer stem-like cells from murine melanoma cell lines. Cell Mol Immunol, 4: 467-472, 2007.
33. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res, 65: 5506-5511, 2005.
34. Inagaki A, Soeda A, Oka N , Kitajima H, Nakagawa J, Motohashi T, Kunisada T, Iwama T: Long-term maintenance of brain tumor stem cell properties under at non-adherent and adherent culture conditions. Biochem Biophys Res Commun, 361: 586-592, 2007.
35. Gou S, Liu T, Wang C, Yin T, Li K, Yang M, Zhou J: Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stemcell properties. Pancreas, 34: 429-435, 2007.
36. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E: let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell, 131: 1109-1123, 2007.
37. Yin S, Li J, Hu C Chen X, Yao M, Yan M, Jiang G, Ge C, Xie H, Wan D: CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer, 120: 1444-1450, 2007.